OREX
Orexigen Therapeutics, Inc.
OREX
OREX
Delisted
OREX was delisted on the 3rd of April, 2018.
52 hedge funds and large institutions have $23.6M invested in Orexigen Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 16 increasing their positions, 10 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less funds holding
Funds holding: 53 → 52 (-1)
Holders
52
Holding in Top 10
1
Calls
$1.79M
Puts
$1.36M
Top Buyers
| 1 | +$906K | |
| 2 | +$765K | |
| 3 | +$752K | |
| 4 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
+$434K |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$405K |
Top Sellers
| 1 | -$81.3K | |
| 2 | -$57K | |
| 3 | -$40K | |
| 4 |
Millennium Management
New York
|
-$28K |
| 5 |
Squarepoint
New York
|
-$27K |